RE-LY trial: both warfarin and dabigatran etexilate reduce GFR

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2015年 / 1558卷 / 1期
关键词：
D O I：
10.1007/s40278-015-3000-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [1] Efficacy and safety of dabigatran versus warfarin from the RE-LY trial
    Avezum, Alvaro
    de Figueiredo Oliveira, Gustavo Bernardes
    Diaz, Rafael
    Gonzalez Hermosillo, Jesus Antonio
    Oldgren, Jonas
    Ripoll, Ernesto Ferreiros
    Noack, Herbert
    Piegas, Leopoldo Soares
    Connolly, Stuart J.
    [J]. OPEN HEART, 2018, 5 (01):
  • [2] Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate
    Lip, G.
    Clemens, A.
    Noack, H.
    Ferreira, J.
    Connolly, S.
    Yusuf, S.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 791 - 791
  • [3] RE-LY: dabigatran superior to warfarin irrespective of INR
    Fricker, Janet
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (10) : 550 - 550
  • [4] DABIGATRAN ETEXILATE VERSUS WARFARIN IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATION: A RE-LY® SUBGROUP ANALYSIS
    Flaker, Greg C.
    Reilly, Paul
    Yusuf, Salim
    Ezekowitz, Mike
    Wallentin, Lars
    Brueckmann, Martina
    Connolly, Stuart
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E62 - E62
  • [5] Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial
    DiNicolantonio, James J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1101 - 1111
  • [6] Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
    Khoo, Chee W.
    Lip, Gregory Y. H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 685 - 687
  • [7] Concomitant use of P-glycoprotein inhibitors with dabigatran or warfarin in the RE-LY trial
    Reilly, P. A.
    Connolly, S. J.
    Ezekowitz, M. D.
    Haertter, S.
    Noack, H.
    Wallentin, L.
    Yusuf, S.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 6 - 6
  • [8] Preliminary results show you can RE-LY (R) on dabigatran etexilate
    不详
    [J]. FUTURE CARDIOLOGY, 2010, 6 (03) : 282 - 282
  • [9] Preliminary results show you can RE-LY (R) on dabigatran etexilate
    不详
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (05) : 621 - 621
  • [10] RE-LY: dabigatran in cardioversion
    Katrina Ray
    [J]. Nature Reviews Cardiology, 2011, 8 (3) : 123 - 123
12345